HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Emergency Contraceptives OTC Access Faces Uphill Struggle

This article was originally published in The Tan Sheet

Executive Summary

The burgeoning movement to persuade FDA to approve emergency contraceptives for over-the-counter use may have to overcome several high hurdles to succeed.

You may also be interested in...



Generic Rx Plan B Approval Points To Possible OTC Equivalents In Near Future

FDA's approval of a generic prescription-only Plan B makes a nonprescription generic of the emergency contraceptive likely, potentially as early as August

Wisconsin Citizen Petition Seeks Plan B Approval For All Ages

The State of Wisconsin has filed a citizen petition to persuade FDA to move Barr Labs' Plan B and any equivalent emergency contraceptives to OTC status without an age restriction

FDA Topsiders Must Testify In Plan B Case – Judge

The Center for Reproductive Rights will be allowed to take depositions from certain FDA "senior decision-makers" in their suit against the agency over decisions related to emergency contraceptive Plan B

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS132623

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel